The efficiency of rifaximin in the correction of the small intestinal bacterial overgrowth syndrome in chronic inflammatory bowel diseases and functional bowel disorders

Background. The article deals with the problem of small intestinal bacterial overgrowth (SIBO) syndrome in patients with chronic inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS), and ways to correct it. The purpose was to determine the incidence of SIBO in Crohn’s disease (CD), u...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Gastroenterologìa
المؤلفون الرئيسيون:	Yu.M. Stepanov, N.S. Fedorova, E.V. Zyhalo
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Zaslavsky O.Yu. 2019-11-01
الموضوعات:	ulcerative colitis crohn’s disease irritable bowel syndrome small intestinal bacterial overgrowth syndrome rifaximin
الوصول للمادة أونلاين:	http://gastro.zaslavsky.com.ua/article/view/182740

مواد مشابهة

The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome
منشور في: (2009-09-01)

Efficiency of management of patients with irritable bowel syndrome with constipation and autoimmune thyroiditis with hypothyroidism using rifaximin
حسب: Yu.A. Onofrijchuk
منشور في: (2025-04-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
حسب: Yu. A. Kucheryavy, وآخرون
منشور في: (2014-08-01)

Prevalence and predictors of small intestinal bacterial overgrowth in inflammatory bowel disease: a meta-analysis
حسب: Xin Feng, وآخرون
منشور في: (2025-01-01)

Advances in Therapy for Irritable Bowel Syndrome with Diarrhea: Role of Rifaximin in Combination with Metronidazole
حسب: Arif A Faruqui
منشور في: (2024-01-01)

Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial
حسب: Gabriela Leite, وآخرون
منشور في: (2024-08-01)

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
حسب: Will Takakura, وآخرون
منشور في: (2020-07-01)

Small Intestinal Bacterial Overgrowth: A Case-Based Review
حسب: Kristen H. Reynolds
منشور في: (2015-11-01)

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
حسب: Paulina Konrad, وآخرون
منشور في: (2018-03-01)

Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
حسب: K. V. Ivashkin, وآخرون
منشور في: (2021-04-01)

Prevalence and risk of small intestinal bacterial overgrowth in patients with rosacea: A systematic review and meta-analysis
حسب: А. R. Khurmatullina, وآخرون
منشور في: (2025-01-01)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
حسب: Xiaojun Zhuang, وآخرون
منشور في: (2018-07-01)

The role of rifaximin in irritable bowel syndrome derived from a network meta-analysis of randomized control trials
حسب: T. Rokkas, وآخرون
منشور في: (2020-07-01)

Diagnostic Implications of Irritable Bowel Syndrome Is an Independent Risk Factor for Undergoing Surgical Interventions in Patients with Inflammatory Bowel Disease
حسب: Yuhan Fu, وآخرون
منشور في: (2023-05-01)

Small Intestinal Bacterial Overgrowth (SIBO): Result of Altered Defensive Mechanism in Gastrointestinal – A Review
حسب: Alvin Hartanto Kurniawan, وآخرون
منشور في: (2020-07-01)

Diagnosis and treatment of small intestinal bacterial overgrowth
حسب: Karolina Zadrozna, وآخرون
منشور في: (2022-11-01)

Small Intestinal Bacterial Overgrowth in Children with Short Bowel Syndrome: Risk Factors, Clinical Presentation and Management—A Single-Center Experience
حسب: Maja Velimirovic, وآخرون
منشور في: (2025-03-01)

Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H2 or CH4 production with severity of IBS
حسب: Philippe Onana Ndong, وآخرون
منشور في: (2023-04-01)

Treatment of small intestinal bacterial overgrowth: Conventional antibiotic therapy and alternative therapy - probiotics and low FODMAP diet
حسب: Maria Litwiniuk, وآخرون
منشور في: (2023-06-01)

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
حسب: Uday C. Ghoshal, وآخرون
منشور في: (2017-03-01)

Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3
حسب: Enzo Vicari, وآخرون
منشور في: (2014-10-01)

Clinical experience with the use of the intestinal antibiotic Rifaximin for celiac disease
حسب: L. S. Оrеshkо, وآخرون
منشور في: (2019-10-01)

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
حسب: Porter Chad K, وآخرون
منشور في: (2012-05-01)

The relationship between small intestinal bacterial overgrowth and constipation in children – a comprehensive review
حسب: Cristina Roxana Mares, وآخرون
منشور في: (2024-06-01)

Rifaximin-Alpha and Other Crystalline Forms of Rifaximin: Are There Any Differences?
حسب: S. K. Zyryanov, وآخرون
منشور في: (2020-11-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19
حسب: A. V. Nalyotov, وآخرون
منشور في: (2022-09-01)

Cross‐Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment
حسب: Junhui Li, وآخرون
منشور في: (2024-11-01)

Comparison of abdominal bloating severity between irritable bowel syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test
حسب: J. Lasa, وآخرون
منشور في: (2012-04-01)

Practical Recommendation of the Scientific Сommunity for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on Small Intestinal Bacterial Overgrowth in Adults
حسب: V. T. Ivashkin, وآخرون
منشور في: (2022-09-01)

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review
حسب: Marilyn Hagan, وآخرون
منشور في: (2021-03-01)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
حسب: Tomasz Wollny, وآخرون
منشور في: (2021-11-01)

Age peculiarities of intestinal microbiocenosis disorders in the patients with ulcerative colitis and Crohn’s disease
حسب: Yu.M. Stepanov, وآخرون
منشور في: (2020-10-01)

Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
حسب: V. T. Ivashkin, وآخرون
منشور في: (2015-07-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
حسب: V. T. Ivashkin, وآخرون
منشور في: (2015-05-01)

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
حسب: Huaizhu Guo, وآخرون
منشور في: (2023-02-01)

Small Bowel Bacterial Overgrowth Syndrome in Patients with Bronchial Asthma
حسب: N. D. Potskhverashvili, وآخرون
منشور في: (2018-09-01)

Editorial: Recent advances in understanding the role and mechanisms of gut microbiota in inflammatory bowel disease and irritable bowel syndrome
حسب: Abbas Yadegar, وآخرون
منشور في: (2024-11-01)

Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management
حسب: Martina Ledergerber, وآخرون
منشور في: (2021-02-01)

Methane, Bacteria, Fungi, and Fermentation: Pathophysiology, Diagnosis and Treatment Strategies for Small Intestinal Bacterial Overgrowth, Intestinal Methanogen Overgrowth and Small Intestinal Fungal Overgrowth
حسب: Adam Wawrzeńczyk, وآخرون
منشور في: (2025-09-01)

Segmental intestinal reconfiguration (SIR) in combined reconstructions for ultrashort bowel syndrome
حسب: Vasily V. Nikolaev, وآخرون
منشور في: (2024-10-01)